Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial
- PMID: 365072
- DOI: 10.1002/ana.410020310
Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial
Abstract
In a double-blind controlled clinical trial on 51 patients with subarachnoid hemorrhage, tranexamic acid, 4 gm per day for ten consecutive days, did not favorably affect the outcome. Neither mortality nor rebleeding rates were improved after a follow-up of three months.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
